Truist Securities Maintains Hold on OrthoPediatrics, Lowers Price Target to $35
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Samuel Brodovsky maintains a Hold rating on OrthoPediatrics (NASDAQ:KIDS) and lowers the price target from $38 to $35.
July 16, 2024 | 1:54 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Truist Securities analyst Samuel Brodovsky maintains a Hold rating on OrthoPediatrics and lowers the price target from $38 to $35.
The lowered price target from $38 to $35 suggests a less optimistic outlook for OrthoPediatrics, which could lead to a short-term negative impact on the stock price. The Hold rating indicates that the stock is expected to perform in line with the market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100